Device Pounce Venous Thrombectomy System

Pounce Venous Thrombectomy System

Payments companies reported to CMS as associated with Pounce Venous Thrombectomy System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
2,322clinicians with associated payments
1company reporting

By year

2023 $349K
2024 $364K
2025 $420K

Payments reported as associated with Pounce Venous Thrombectomy System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $697K
Vascular Surgery $231K
Internal Medicine $54K
Vascular & Interventional Radiology $46K
Cardiovascular Disease $34K
Surgery $9,809

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Pounce Venous Thrombectomy System

These are the largest totals companies reported as associated with Pounce Venous Thrombectomy System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gary Ansel Columbus, OH Interventional Cardiology $534,477.89
Lucas Ferrer Cardona San Antonio, TX Vascular Surgery $64,331.70
Bruce Gray Greenville, SC Internal Medicine $50,106.51
Peter Schneider Honolulu, HI Vascular Surgery $48,894.06
Nachiket Patel Mesa, AZ Interventional Cardiology $45,354.18
Dean Ferrera East Chicago, IN Interventional Cardiology $31,335.13
Aloke Finn Baltimore, MD Interventional Cardiology $24,800.00
Pavan Kavali Saint Louis, MO Vascular & Interventional Radiology $14,347.23
Kevin Onofrey Detroit, MI Vascular Surgery $12,579.60
Hady Lichaa Murfreesboro, TN Cardiovascular Disease $9,922.94

Prescribed Pounce Venous Thrombectomy System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.